Let-7b miRNA-loaded nanostructures inhibited human tongue squamous cell carcinoma metastasis by the MOR-SRC-EGFR axis

IF 3.6 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Haojie Yang , Weixiong Chen , Zicong Tan , Junjie Lin , Zhongqi Liu , Fengtao Ji , Xiaoyan Huang , Phei Er Saw , Minghui Cao
{"title":"Let-7b miRNA-loaded nanostructures inhibited human tongue squamous cell carcinoma metastasis by the MOR-SRC-EGFR axis","authors":"Haojie Yang ,&nbsp;Weixiong Chen ,&nbsp;Zicong Tan ,&nbsp;Junjie Lin ,&nbsp;Zhongqi Liu ,&nbsp;Fengtao Ji ,&nbsp;Xiaoyan Huang ,&nbsp;Phei Er Saw ,&nbsp;Minghui Cao","doi":"10.1016/j.crbiot.2024.100213","DOIUrl":null,"url":null,"abstract":"<div><p>miRNA is a type of classic non-coding RNA which is enriched in cancer. Various studies reported that miRNA be involved in the progression and metastasis of TSCC. Exploring pivotal miRNAs and elaborating the mechanisms inducing metastasis are important for improving the prognosis of TSCC patients. Here, Let-7b miRNA was identified as a significant factor contributing to metastasis of TSCC via directly targeting the 3′UTR of MOR mRNA, which leads to abnormally high expression of MOR protein. MOR<!--> <!-->might<!--> <!-->bind<!--> <!-->with<!--> <!-->SRC<!--> <!-->and<!--> <!-->potentially<!--> <!-->activate<!--> <!-->p-EGFR<!--> <!-->through<!--> <!-->SRC. As a treatment modality, Let-7b miRNA mimics were encapsulated into the endosomal pH-responsive nanoparticles. NPs (Let-7b miRNA mimics) significantly inhibited Cal27 cells <em>in vitro</em> and <em>in vivo</em> metastatic model. Altogether, our data revealed that Let-7b miRNA-MOR-SRC-EGFR axis might be an effective therapeutic target in TSCC metastasis.</p></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S259026282400039X/pdfft?md5=4fd4ff817763aceae5fcdd08e2993d62&pid=1-s2.0-S259026282400039X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research in Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S259026282400039X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

miRNA is a type of classic non-coding RNA which is enriched in cancer. Various studies reported that miRNA be involved in the progression and metastasis of TSCC. Exploring pivotal miRNAs and elaborating the mechanisms inducing metastasis are important for improving the prognosis of TSCC patients. Here, Let-7b miRNA was identified as a significant factor contributing to metastasis of TSCC via directly targeting the 3′UTR of MOR mRNA, which leads to abnormally high expression of MOR protein. MOR might bind with SRC and potentially activate p-EGFR through SRC. As a treatment modality, Let-7b miRNA mimics were encapsulated into the endosomal pH-responsive nanoparticles. NPs (Let-7b miRNA mimics) significantly inhibited Cal27 cells in vitro and in vivo metastatic model. Altogether, our data revealed that Let-7b miRNA-MOR-SRC-EGFR axis might be an effective therapeutic target in TSCC metastasis.

Abstract Image

负载Let-7b miRNA的纳米结构通过MOR-SRC-EGFR轴抑制人舌鳞癌转移
miRNA 是一种典型的非编码 RNA,在癌症中富集。多项研究表明,miRNA 参与了 TSCC 的进展和转移。探索关键的miRNA并阐明诱导转移的机制对改善TSCC患者的预后非常重要。研究发现,Let-7b miRNA直接靶向MOR mRNA的3′UTR,从而导致MOR蛋白的异常高表达,是导致TSCC转移的重要因素。MOR可能与SRC结合,并可能通过SRC激活p-EGFR。作为一种治疗方式,Let-7b miRNA模拟物被封装到内泌体pH响应纳米颗粒中。NPs(Let-7b miRNA mimics)能显著抑制体外和体内转移模型中的Cal27细胞。总之,我们的数据揭示了Let-7b miRNA-MOR-SRC-EGFR轴可能是TSCC转移的有效治疗靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Research in Biotechnology
Current Research in Biotechnology Biochemistry, Genetics and Molecular Biology-Biotechnology
CiteScore
6.70
自引率
3.60%
发文量
50
审稿时长
38 days
期刊介绍: Current Research in Biotechnology (CRBIOT) is a new primary research, gold open access journal from Elsevier. CRBIOT publishes original papers, reviews, and short communications (including viewpoints and perspectives) resulting from research in biotechnology and biotech-associated disciplines. Current Research in Biotechnology is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is a companion to the highly regarded review journal Current Opinion in Biotechnology (2018 CiteScore 8.450) and is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信